Suchergebnisse - "NAFLD"

Microbial biotherapeutic metabolite alleviates liver injury by restoring hepatic lipid metabolism through PPARα across the gut-liver axis

Autoren: Kramer, Dylan J Wang, Weicang Loque, Ikaika et al.

Quelle: mBio. 16(9)

Schlagwörter: 3101 Biochemistry and Cell Biology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 31 Biological Sciences (for-2020), Infectious Diseases (rcdc), Digestive Diseases (rcdc), Microbiome (rcdc), Liver Disease (rcdc), Biotechnology (rcdc), Orphan Drug (rcdc), Nutrition (rcdc), Regenerative Medicine (rcdc), Rare Diseases (rcdc), Chronic Liver Disease and Cirrhosis (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), 5.1 Pharmaceuticals (hrcs-rac), 1.1 Normal biological development and functioning (hrcs-rac), Infection (hrcs-hc), Oral and gastrointestinal (hrcs-hc), 3 Good Health and Well Being (sdg), PPAR alpha (mesh), Animals (mesh), Lipid Metabolism (mesh), Liver (mesh), Gastrointestinal Microbiome (mesh), Mice (mesh), Male (mesh), Mice, Inbred C57BL (mesh), Disease Models, Animal (mesh), Dysbiosis (mesh), Liver Regeneration (mesh), Intestinal Mucosa (mesh), NAFLD, gut-liver axis, microbial metabolite, biotherapeutic, 10-hydroxystearic acid, Intestinal Mucosa (mesh), Liver (mesh), Animals (mesh), Mice, Inbred C57BL (mesh), Mice (mesh), Disease Models, Animal (mesh), PPAR alpha (mesh), Liver Regeneration (mesh), Male (mesh), Lipid Metabolism (mesh), Dysbiosis (mesh), Gastrointestinal Microbiome (mesh), 10-hydroxystearic acid, NAFLD, biotherapeutic, gut-liver axis, microbial metabolite, PPAR alpha (mesh), Animals (mesh), Lipid Metabolism (mesh), Liver (mesh), Gastrointestinal Microbiome (mesh), Mice (mesh), Male (mesh), Mice, Inbred C57BL (mesh), Disease Models, Animal (mesh), Dysbiosis (mesh), Liver Regeneration (mesh), Intestinal Mucosa (mesh), 0605 Microbiology (for), 3101 Biochemistry and cell biology (for-2020), 3107 Microbiology (for-2020), 3207 Medical microbiology (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/80n8n8f7
https://escholarship.org/content/qt80n8n8f7/qt80n8n8f7.pdf

Mecanismes moleculars que participen en la regulació de la Sex Hormone-Binding Globulin: factors nutricionals i fibrosi hepàtica

Autoren: Briansó Llort, Laura

Thesis Advisors: Martinez Selva, David, Hernández Pascual, Cristina, Simó Canonge, Rafael, Meseguer Navarro, Ana

Quelle: TDX (Tesis Doctorals en Xarxa)

Schlagwörter: SHBG, Fibrosis, NAFLD, Ciències Experimentals

Dateibeschreibung: application/pdf

Zugangs-URL: http://hdl.handle.net/10803/687893

Metabolismo del hierro y de la serotonina en la enfermedad del hígado graso no alcohólico

Autoren: Binetti, Jessica Angela

Weitere Verfasser: University/Department: Universitat Rovira i Virgili. Departament de Medicina i Cirurgia

Thesis Advisors: Richart Jurado, Cristobal Manuel, Auguet Quintillà, Maria Teresa

Quelle: TDX (Tesis Doctorals en Xarxa)

Schlagwörter: MFGNA, Hepcidina, Serotonina, EHGNA, NAFLD, Hepcidine, Serotonin, Ciències de la salut

Time: 616.3

Dateibeschreibung: application/pdf

Zugangs-URL: http://hdl.handle.net/10803/675960

Vascular endothelial growth factor A, a potential non-invasive biomarker for metabolic dysfunction-associated steatotic liver disease progression

Autoren: Jönsson, Cecilia Ma'ayeh, Showgy Zhang, Boxi et al.

Quelle: Clinical Biochemistry. 137

Schlagwörter: Biomarkers, Liver biopsy, NAFLD, Non-invasive tests (NITs), Olink Target 96, VEGFA

Dateibeschreibung: electronic

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-213000
https://doi.org/10.1016/j.clinbiochem.2025.110920

Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD

Autoren: Hegmar, Hannes Wiggers, Thomas Nasr, Patrik et al.

Quelle: Journal of Internal Medicine. 296(2):177-186

Schlagwörter: MASLD, NAFLD, liver fibrosis, noninvasive tests

Dateibeschreibung: print

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-114613
https://doi.org/10.1111/joim.13813

Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease

Autoren: Nasr, Patrik Shang, Ying Wester, Axel et al.

Quelle: Liver international. 44(11):3050-3059

Schlagwörter: cirrhosis, MALO, MASLD, NAFLD, socioeconomic status

Dateibeschreibung: electronic

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-207425
https://liu.diva-portal.org/smash/get/diva2:1896159/FULLTEXT01.pdf

A unified framework for prediction of liver steatosis dynamics in response to different diet and drug interventions

Autoren: Simonsson, Christian Nyman, Elin Gennemark, Peter et al.

Quelle: Clinical Nutrition. 43(6):1532-1543

Schlagwörter: Mathematical modelling, NAFLD, Steatosis, Systems biology, Diets

Dateibeschreibung: electronic

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-205433
https://doi.org/10.1016/j.clnu.2024.05.017

Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant

Autoren: Jönsson, Cecilia Bergram, Martin Kechagias, Stergios, Professor et al.

Quelle: Scandinavian Journal of Gastroenterology. 59(6):737-741

Schlagwörter: NAFLD, biomarkers, NIT, liver biopsy

Dateibeschreibung: electronic

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-202487
https://liu.diva-portal.org/smash/get/diva2:1851689/FULLTEXT01.pdf

Targeting PNPLA3 to Treat MASH and MASH Related Fibrosis and Cirrhosis

Autoren: Lindén, Daniel Tesz, Gregory Loomba, Rohit

Quelle: Liver International. 45(4)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Liver Disease (rcdc), Prevention (rcdc), Precision Medicine (rcdc), Chronic Liver Disease and Cirrhosis (rcdc), Genetics (rcdc), Clinical Research (rcdc), Clinical Trials and Supportive Activities (rcdc), Digestive Diseases (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Oral and gastrointestinal (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Membrane Proteins (mesh), Liver Cirrhosis (mesh), Lipase (mesh), Fatty Liver (mesh), Genetic Predisposition to Disease (mesh), Animals (mesh), Acyltransferases (mesh), Phospholipases A2, Calcium-Independent (mesh), MASH, MASLD, metALD, NAFLD, NASH, PNPLA3, precision medicine, SLD, steatotic liver disease, Animals (mesh), Humans (mesh), Fatty Liver (mesh), Liver Cirrhosis (mesh), Genetic Predisposition to Disease (mesh), Lipase (mesh), Acyltransferases (mesh), Membrane Proteins (mesh), Phospholipases A2, Calcium-Independent (mesh), MASH, MASLD, NAFLD, NASH, PNPLA3, SLD, metALD, precision medicine, steatotic liver disease, Humans (mesh), Membrane Proteins (mesh), Liver Cirrhosis (mesh), Lipase (mesh), Fatty Liver (mesh), Genetic Predisposition to Disease (mesh), Animals (mesh), Acyltransferases (mesh), Phospholipases A2, Calcium-Independent (mesh), Gastroenterology & Hepatology (science-metrix)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/3198r47n
https://escholarship.org/content/qt3198r47n/qt3198r47n.pdf

A Scientometric Assessment of MAFLD in Children and Adolescents from 2007–2024

Autoren: Raju Vaishya Anupam Sibal Brij Mohan Gupta et al.

Quelle: National Board of Examinations Journal of Medical Sciences, Vol Volume 3, Iss 7, Pp 862-883 (2025)

Schlagwörter: masld, nash, Medicine, mafld, nafld, bibliometrics, fatty liver

Zugangs-URL: https://doaj.org/article/525769aa97fc4a44af92e74556a5aa44

The Rising Global Burden of MASLD and Other Metabolic Diseases (2000–2021)

Autoren: Pojsakorn Danpanichkul Kanokphong Suparan Luis Antonio Diaz et al.

Quelle: United European Gastroenterology Journal. 13:1141-1154

Schlagwörter: MASH, MASLD, dyslipidemia, epidemiology, global health, hypertension, liver disease, non‐alcoholic fatty liver disease (NAFLD), obesity, type 2 diabetes

Dateibeschreibung: application/pdf

Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023

Autoren: Donghee Kim Rohit Loomba Aijaz Ahmed

Quelle: Clin Mol Hepatol
Clinical and Molecular Hepatology, Vol 31, Iss 3, Pp e235-e238 (2025)

Schlagwörter: prevalence, sld, RC799-869, nafld, Diseases of the digestive system. Gastroenterology, nhanes, Letter to the Editor

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39736264
https://doaj.org/article/08723fa5859a4f5cbb7204f7f78783bd

Relevance of the epigenetic regulation exercised by hepatic microRNAs in the fatty liver arena: from the bedside to the bench

Autoren: Latorre Luque, Jèssica

Weitere Verfasser: University/Department: Universitat de Girona. Departament de Ciències Mèdiques

Thesis Advisors: Ortega Delgado, Francisco José, Fernández-Real Lemos, José Manuel

Quelle: TDX (Tesis Doctorals en Xarxa)

Schlagwörter: MicroRNAs, Non-alcoholic fatty liver disease (NAFLD), Fatty liver, Fetge gras, Hígado graso, Epigenetics, Epigenètica, Epigenética, Metabolism, Metabolisme, Triglycerides, Triglicèrids, Triglicéridos, Chronic liver diseases, Malalties hepàtiques cròniques, Enfermedades epáticas crónicas

Time: 616.3

Dateibeschreibung: application/pdf

Zugangs-URL: http://hdl.handle.net/10803/671499

Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease

Autoren: Nychas, Emmanouil Marfil-Sánchez, Andrea Chen, Xiuqiang et al.

Quelle: Microbiome. 13(1)

Schlagwörter: 3107 Microbiology (for-2020), 31 Biological Sciences (for-2020), Machine Learning and Artificial Intelligence (rcdc), Obesity (rcdc), Chronic Liver Disease and Cirrhosis (rcdc), Liver Disease (rcdc), Nutrition (rcdc), Genetics (rcdc), Hepatitis (rcdc), Microbiome (rcdc), Digestive Diseases (rcdc), Prevention (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Metabolic and endocrine (hrcs-hc), Oral and gastrointestinal (hrcs-hc), Cardiovascular (hrcs-hc), Non-alcoholic Fatty Liver Disease (mesh), Humans (mesh), Gastrointestinal Microbiome (mesh), Male (mesh), Metagenomics (mesh), Female (mesh), Bacteria (mesh), Middle Aged (mesh), Adult (mesh), Machine Learning (mesh), Obesity (mesh), NAFLD, Gut microbiota, Metabolic diseases, Machine learning, Network analysis, Metabolomics, Microbial consortia, Humans (mesh), Bacteria (mesh), Obesity (mesh), Adult (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Metagenomics (mesh), Non-alcoholic Fatty Liver Disease (mesh), Machine Learning (mesh), Gastrointestinal Microbiome (mesh), Gut microbiota, Machine learning, Metabolic diseases, Metabolomics, Microbial consortia, NAFLD, Network analysis, Non-alcoholic Fatty Liver Disease (mesh), Humans (mesh), Gastrointestinal Microbiome (mesh), Male (mesh), Metagenomics (mesh), Female (mesh), Bacteria (mesh), Middle Aged (mesh), Adult (mesh), Machine Learning (mesh), Obesity (mesh), 0602 Ecology (for), 0605 Microbiology (for), 1108 Medical Microbiology (for), 3104 Evolutionary biology (for-2020), 3107 Microbiology (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/6415v778
https://escholarship.org/content/qt6415v778/qt6415v778.pdf

MetALD: New Perspectives on an Old Overlooked Disease

Autoren: Ayares, Gustavo Diaz, Luis Antonio Idalsoaga, Francisco et al.

Quelle: Liver International. 45(5)

Schlagwörter: Biomedical and Clinical Sciences, Clinical Sciences, Nutrition, Prevention, Substance Misuse, Liver Disease, Digestive Diseases, Chronic Liver Disease and Cirrhosis, Clinical Research, Alcoholism, Alcohol Use and Health, 2.1 Biological and endogenous factors, 4.1 Discovery and preclinical testing of markers and technologies, Oral and gastrointestinal, Good Health and Well Being, Humans, Risk Factors, Alcohol Drinking, Terminology as Topic, Disease Progression, Liver Diseases, Alcoholic, Fatty Liver, Metabolic Syndrome, alcoholic liver disease, alcohol-related liver disease, ametabolic dysfunction-associated steatotic liver disease, cirrhosisalcoholic cirrhosis, MASLD, NAFLD, non-alcoholic fatty liver disease, alcohol‐related liver disease, ametabolic dysfunction‐associated steatotic liver disease, non‐alcoholic fatty liver disease, Gastroenterology & Hepatology, Clinical sciences

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/9m66829r
https://escholarship.org/content/qt9m66829r/qt9m66829r.pdf

Assessing Diagnostic and Therapeutic Targets in Obesity-Associated Liver Diseases

Autoren: Cabré Casares, Noemí

Weitere Verfasser: University/Department: Universitat Rovira i Virgili. Departament de Medicina i Cirurgia

Thesis Advisors: Joven Maried, Jorge

Quelle: TDX (Tesis Doctorals en Xarxa)

Schlagwörter: Obesitat, Metabolisme, NAFLD, Obesidad, Metabolismo, Obesity, Metabolism, Ciències de la salut

Dateibeschreibung: application/pdf

Zugangs-URL: http://hdl.handle.net/10803/667718

An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography

Autoren: Liang, Jia-xu Ampuero, Javier Niu, Hao et al.

Quelle: Journal of Hepatology. 79(3):592-604

Schlagwörter: Elastography, Magnetic Resonance, Fibrosis, NAFLD, NASH, GGT

Dateibeschreibung: electronic

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-520221
https://doi.org/10.1016/j.jhep.2023.04.025

Advanced Microbiome Therapeutics Accelerate MASLD Recovery by Restoring Intestinal Microbiota Equilibrium and the Gut-Liver Axis in a Mouse Model

Autoren: Johnson Lok Congjia Chen Valeria Iannone et al.

Quelle: Journal of Agricultural and Food Chemistry. 73:15199-15214

Schlagwörter: insulin-like growth factor 1, aldafermin, E. coli Nissle 1917, integrative multi-omics, non-alcoholic fatty liver disease (NAFLD), fbroblast growth factor 19

Dateibeschreibung: application/pdf

Zugangs-URL: https://erepo.uef.fi/handle/123456789/35669

The Link between NAFLD and Colorectal Cancer: Insights from Liver Function Enzymes and Serum Biomarkers in a Case-Control Study

Autoren: Yasir H. Sabah Firas Hassan

Quelle: مجلة مركز بحوث التقنيات الاحيائية, Vol 19, Iss 2 (2025)

Schlagwörter: QH301-705.5, NAFLD, LFT, cathepsin B, Obestatine, Biology (General), Biomarkers, TP248.13-248.65, CRC, Biotechnology

Zugangs-URL: https://doaj.org/article/2a407c71b5744e70b1f0f49b5531608e

Study of association and diagnostic utility of novel anthropometric and lipid indices for nonalcoholic fatty liver disease: A hospital-based study

Autoren: Anand K. Pyati Sakthivadivel Varatharajan Abhishek Arora et al.

Quelle: J Family Med Prim Care
Journal of Family Medicine and Primary Care, Vol 14, Iss 6, Pp 2365-2373 (2025)

Schlagwörter: vai, cmi, lap, Medicine, Original Article, lipid indices, anthropometric, nafld, tyg

Zugangs-URL: https://doaj.org/article/400ba1689013449da5e5340a51c89c05